Gemfibrozil attenuates doxorubicin induced toxicity in renal tissues of male rats by reducing the oxidative insult and inflammation

References

• Aebi H. 1984. Catalase in vitro. Methods Enzymol. 105:121–126.
   PubMed Web of Science ®Google Scholar
• Altinkaynak Y, Kural B, Akcan BA, Bodur A, Ozer S, Yulug E, Mungan S, Kaya C, Orem A. 2018. Protective effects of L-theanine against doxorubicin-induced nephrotoxicity in rats. Biomed Pharmacother. 108:1524–1534. doi:10.1016/j.biopha.2018.09.171.
   PubMed Web of Science ®Google Scholar
• Arafa MH, Mohammad NS, Atteia HH, Abd-Elaziz HR. 2014. Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats. J Physiol Biochem. 70:701–711. doi:10.1007/s13105-014-0339-y.
   PubMed Web of Science ®Google Scholar
• Bazmandegan G, Amirteimoury M, Kaeidi A, Shamsizadeh A, Khademalhosseini M, Nematollahi MH, Hassanipour M, Fatemi I. 2019. Sumatriptan ameliorates renal injury induced by cisplatin in mice. Iran J Basic Med Sci. 22:563. doi:10.22038/ijbms.2019.33620.8020.
   PubMed Web of Science ®Google Scholar
• Behiry S, Rabie A, Kora M, Ismail W, Sabry D, Zahran A. 2018. Effect of combination sildenafil and gemfibrozil on cisplatin-induced nephrotoxicity; role of heme oxygenase-1. Ren Fail. 40:371–378. doi:10.1080/0886022X.2018.1455596.
   PubMed Web of Science ®Google Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248–254. doi:10.1016/0003-2697(76)90527-3.
   PubMed Web of Science ®Google Scholar
• Buege JA, Aust SD. 1978. Microsomal lipid peroxidation. Methods Enzymol. 52:302–310.
   PubMedGoogle Scholar
• Calkin AC, Cooper ME, Jandeleit-Dahm KA, Allen TJ. 2006. Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation. Diabetologia. 49:766–774. doi:10.1007/s00125-005-0102-6.
   PubMed Web of Science ®Google Scholar
• Camara-Lemarroy CR, Guzman De La Garza FJ, Cordero-Perez P, Ibarra-Hernandez JM, Munoz-Espinosa LE, Fernandez-Garza NE. 2015. Gemfibrozil attenuates the inflammatory response and protects rats from abdominal sepsis. Exp Ther Med. 9:1018–1022. doi:10.3892/etm.2015.2190.
   PubMed Web of Science ®Google Scholar
• Dehnamaki F, Karimi A, Pilevarian AA, Fatemi I, Hakimizadeh E, Kaeidi A, Allahtavakoli M, Rahmani MR, Khademalhosseini M, Bazmandegan G. 2018. Treatment with troxerutin protects against cisplatin-induced kidney injury in mice. Acta Chir Belg. 119:31–37. doi:10.1080/00015458.2018.1455418.
   PubMed Web of Science ®Google Scholar
• Ehsani V, Amirteimoury M, Taghipour Z, Shamsizadeh A, Bazmandegan G, Rahnama A, Khajehasani F, Fatemi I. 2017. Protective effect of hydroalcoholic extract of Pistacia vera against gentamicin-induced nephrotoxicity in rats. Ren Fail. 39:519–525. doi:10.1080/0886022X.2017.1326384.
   PubMed Web of Science ®Google Scholar
• Ellman GL. 1959. Tissue sulfhydryl groups. Arch Biochem Biophys. 82:70–77. doi:10.1016/0003-9861(59)90090-6.
   PubMed Web of Science ®Google Scholar
• Feldman AT, Wolfe D. 2014. Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 1180:31–43.
   PubMedGoogle Scholar
• Ghaznavi H, Fatemi I, Kalantari H, Hosseini Tabatabaei SMT, Mehrabani M, Gholamine B, Kalantar M, Mehrzadi S, Goudarzi M. 2017. Ameliorative effects of gallic acid on gentamicin-induced nephrotoxicity in rats. J Asian Nat Prod Res. 20:1182–1193. doi:10.1080/10286020.2017.1384819.
   PubMed Web of Science ®Google Scholar
• Goudarzi M, Khodayar MJ, Hosseini Tabatabaei SMT, Ghaznavi H, Fatemi I, Mehrzadi S. 2017. Pretreatment with melatonin protects against cyclophosphamide‐induced oxidative stress and renal damage in mice. Fundam Clin Pharmacol. 31:625–635.
   PubMed Web of Science ®Google Scholar
• Guo Q, Wang G, Liu X, Namura S. 2009. Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice. Brain Res. 1279:121–130. doi:10.1016/j.brainres.2009.04.055.
   PubMed Web of Science ®Google Scholar
• Haybar H, Goudarzi M, Mehrzadi S, Aminzadeh A, Khodayar MJ, Kalantar M, Fatemi I. 2019. Effect of gemfibrozil on cardiotoxicity induced by doxorubicin in male experimental rats. Biomed Pharmacother. 109:530–535. doi:10.1016/j.biopha.2018.10.101.
   PubMed Web of Science ®Google Scholar
• Hosseini A, Sahebkar A. 2017. Reversal of doxorubicin-induced cardiotoxicity by using phytotherapy: a review. J Pharmacopunct. 20:243–256.
   PubMed Web of Science ®Google Scholar
• Khalilzadeh M, Abdollahi A, Abdolahi F, Abdolghaffari AH, Dehpour AR, Jazaeri F. 2018. Protective effects of magnesium sulfate against doxorubicin induced cardiotoxicity in rats. Life Sci. 207:436–441. doi:10.1016/j.lfs.2018.06.022.
   PubMed Web of Science ®Google Scholar
• Khan TH, Ganaie MA, Alharthy KM, Madkhali H, Jan BL, Sheikh IA. 2018. Naringenin prevents doxorubicin-induced toxicity in kidney tissues by regulating the oxidative and inflammatory insult in Wistar rats. Arch Physiol Biochem. 8:1–8. doi:10.1080/13813455.2018.1529799.
   Google Scholar
• Kobylinska LI, Boiko NM, Panchuk RR, Grytsyna II, Klyuchivska OY, Biletska LP, Lesyk RB, Zіmenkovsky BS, Stoika RS. 2016. Putative anticancer potential of novel 4-thiazolidinone derivatives: cytotoxicity toward rat C6 glioma in vitro and correlation of general toxicity with the balance of free radical oxidation in rats. Croat Med J. 57:151–163. doi:10.3325/cmj.2016.57.151.
   PubMed Web of Science ®Google Scholar
• Levine RL, Williams JA, Stadtman EP, Shacter E. 1994. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233:346–357.
   PubMed Web of Science ®Google Scholar
• Martin JP, Dailey M, Sugarman E. 1987. Negative and positive assays of superoxide dismutase based on hematoxylin autoxidation. Arch Biochem Biophys. 255:329–336. doi:10.1016/0003-9861(87)90400-0.
   PubMed Web of Science ®Google Scholar
• Mehrzadi S, Fatemi I, Malayeri AR, Khodadadi A, Mohammadi F, Mansouri E, Rashno M, Goudarzi M. 2018. Ellagic acid mitigates sodium arsenite-induced renal and hepatic toxicity in male Wistar rats. Pharmacol Rep. 70:712–719. doi:10.1016/j.pharep.2018.02.007.
   PubMed Web of Science ®Google Scholar
• Mohagheghi F, Khalaj L, Ahmadiani A, Rahmani B. 2013. Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion. Neurotox Res. 23:225–237. doi:10.1007/s12640-012-9338-3.
   PubMed Web of Science ®Google Scholar
• Nagai K, Fukuno S, Otani K, Nagamine Y, Omotani S, Hatsuda Y, Myotoku M, Konishi H. 2018. Prevention of doxorubicin-induced renal toxicity by theanine in rats. Pharmacology. 101:219–224. doi:10.1159/000486625.
   PubMed Web of Science ®Google Scholar
• Naji Ebrahimi Yazd Z, Hosseinian S, Shafei MN, Ebrahimzadeh Bideskan A, Entezari Heravi N, Parhizgar S, Shahraki S, Samadi Noshahr Z, Mahzari S, Khajavi Rad A. 2018. Protection against doxorubicin-induced nephropathy by Plantago major in rat. Iran J Kidney Dis. 12:99–106.
   PubMed Web of Science ®Google Scholar
• Nikravesh H, Khodayar MJ, Mahdavinia M, Mansouri E, Zeidooni L, Dehbashi F. 2018. Protective effect of gemfibrozil on hepatotoxicity induced by acetaminophen in mice: the importance of oxidative stress suppression. Adv Pharm Bull. 8:331–339. doi:10.15171/apb.2018.038.
   PubMed Web of Science ®Google Scholar
• Ozansoy G, Akin B, Aktan F, Karasu C. 2001. Short-term gemfibrozil treatment reverses lipid profile and peroxidation but does not alter blood glucose and tissue antioxidant enzymes in chronically diabetic rats. Mol Cell Biochem. 216:59–63. doi:10.1023/A:1011000327529.
   PubMed Web of Science ®Google Scholar
• Pahan K, Jana M, Liu X, Taylor BS, Wood C, Fischer SM. 2002. Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes. J Biol Chem. 277:45984–45991. doi:10.1074/jbc.M200250200.
   PubMed Web of Science ®Google Scholar
• Pugazhendhi A, Edison T, Velmurugan BK, Jacob JA, Karuppusamy I. 2018. Toxicity of doxorubicin (Dox) to different experimental organ systems. Life Sci. 200:26–30. doi:10.1016/j.lfs.2018.03.023.
   PubMed Web of Science ®Google Scholar
• Sutken E, Inal M, Ozdemir F. 2006. Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects. Saud Med J. 27:453–459.
   PubMed Web of Science ®Google Scholar
• Taghipour Z, Kaviani E, Kaeidi A, Shamsizadeh A, Hassanshahi J, Fatemi I. 2019. Atorvastatin attenuates D-galactose-induced hepatorenal toxicity in mice: an experimental study with histopathological evaluations. Physiol Pharmacol. 23:36–43.
   Web of Science ®Google Scholar
• Toora BD, Rajagopal G. 2002. Measurement of creatinine by Jaffe’s reaction─determination of concentration of sodium hydroxide required for maximum color development in standard, urine and protein free filtrate of serum. Ind J Exp Biol. 40:352–354.
   PubMedGoogle Scholar
• Tracey WR, Linden J, Peach MJ, Johns RA. 1990. Comparison of spectrophotometric and biological assays for nitric oxide (NO) and endothelium-derived relaxing factor (EDRF): nonspecificity of the diazotization reaction for NO and failure to detect EDRF. J Pharmacol Exp Ther. 252:922–928.
   PubMed Web of Science ®Google Scholar
• Zhang QL, Yang JJ, Zhang HS. 2018. Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy. Biomed Pharmacother. 109:71–83. doi:10.1016/j.biopha.2018.07.037.
   PubMed Web of Science ®Google Scholar
• Zhao SP, Ye HJ, Zhou HN, Nie S, Li QZ. 2003. Gemfibrozil reduces release of tumor necrosis factor-alpha in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease. Clin Chim Acta. 332:61–67. doi:10.1016/S0009-8981(03)00123-2.
   PubMed Web of Science ®Google Scholar